Search Results Search Sort by RelevanceMost Recent Case and Commentary Oct 2018 Do Infant Formula Giveaways Undermine or Support Women’s Choices? Stephanie Morain, PhD, MPH and Anne Barnhill, PhD Health care organizations have obligations to support all patients mothering newborns in making informed choices about formula and breast feeding. AMA J Ethics. 2018;20(10):E924-931. doi: 10.1001/amajethics.2018.924. Viewpoint Feb 2022 What Law Enforcement Can Learn From Health Care About Moral Injury Wendy Dean, MD Identifying when and how personal, professional, or social value systems are affected by moral injury can inform efforts to mitigate it. AMA J Ethics. 2022;24(2):E160-163. doi: 10.1001/amajethics.2022.160. Podcast Feb 2022 Author Interview: “What Law Enforcement Can Learn From Health Care About Moral Injury” Dr Wendy Dean joins Ethics Talk to discuss her article: “What Law Enforcement Can Learn From Health Care About Moral Injury.” Case and Commentary Sep 2022 What Do We Owe Health Workers Earning Low Wages Who Are at Risk of Harm? Constance E. George, MD, MA Psychiatric aides and technicians are part of direct care workforces in inpatient units who are subject to high rates of violence but earn far less than higher-status clinicians. AMA J Ethics. 2022;24(9):E830-838. doi: 10.1001/amajethics.2022.830. Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Health Law Dec 2020 Reexamining the Flawed Legal Basis of the “Dead Donor Rule” as a Foundation for Organ Donation Policy Scott J. Schweikart, JD, MBE The DDR requires organ donors to be dead according to legal criteria prior to organ removal, and it’s rooted in fears of civil and criminal liability. AMA J Ethics. 2020;22(12):E1019-1024. doi: 10.1001/amajethics.2020.1019. Policy Forum Dec 2020 Guidance for Physicians Who Wish to Influence Policy Development on Determination of Death by Neurologic Criteria Michael A. Rubin, MD, MA Lobbying, maintaining diagnostic skill, participating in national societies, and contributing to robust discourse can influence practice and policy. AMA J Ethics. 2020;22(12):E1033-1037. doi: 10.1001/amajethics.2020.1033. Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542. Case and Commentary Oct 2023 Should Antipsychotics’ Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults’ Behavioral Symptoms in Short-Staffed Units? Alex Rollo, MD, Jeena Kar, DO, Uma Suryadevara, MD, and Mary Camp, MD This commentary considers how to manage agitation in patients with dementia. AMA J Ethics. 2023;25(10):E725-732. doi: 10.1001/amajethics.2023.725. Medicine and Society Oct 2023 Prioritizing Diversion and Decarceration of People With Dementia Lay Kodama, MD, PhD, Brie Williams, MD, MS, and Nathaniel P. Morris, MD An aging prison population means more people who are incarcerated will experience dementia and related symptoms. AMA J Ethics. 2023;25(10):E783-790. doi: 10.1001/amajethics.2023.783. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Case and Commentary Oct 2018 Do Infant Formula Giveaways Undermine or Support Women’s Choices? Stephanie Morain, PhD, MPH and Anne Barnhill, PhD Health care organizations have obligations to support all patients mothering newborns in making informed choices about formula and breast feeding. AMA J Ethics. 2018;20(10):E924-931. doi: 10.1001/amajethics.2018.924.
Viewpoint Feb 2022 What Law Enforcement Can Learn From Health Care About Moral Injury Wendy Dean, MD Identifying when and how personal, professional, or social value systems are affected by moral injury can inform efforts to mitigate it. AMA J Ethics. 2022;24(2):E160-163. doi: 10.1001/amajethics.2022.160.
Podcast Feb 2022 Author Interview: “What Law Enforcement Can Learn From Health Care About Moral Injury” Dr Wendy Dean joins Ethics Talk to discuss her article: “What Law Enforcement Can Learn From Health Care About Moral Injury.”
Case and Commentary Sep 2022 What Do We Owe Health Workers Earning Low Wages Who Are at Risk of Harm? Constance E. George, MD, MA Psychiatric aides and technicians are part of direct care workforces in inpatient units who are subject to high rates of violence but earn far less than higher-status clinicians. AMA J Ethics. 2022;24(9):E830-838. doi: 10.1001/amajethics.2022.830.
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Health Law Dec 2020 Reexamining the Flawed Legal Basis of the “Dead Donor Rule” as a Foundation for Organ Donation Policy Scott J. Schweikart, JD, MBE The DDR requires organ donors to be dead according to legal criteria prior to organ removal, and it’s rooted in fears of civil and criminal liability. AMA J Ethics. 2020;22(12):E1019-1024. doi: 10.1001/amajethics.2020.1019.
Policy Forum Dec 2020 Guidance for Physicians Who Wish to Influence Policy Development on Determination of Death by Neurologic Criteria Michael A. Rubin, MD, MA Lobbying, maintaining diagnostic skill, participating in national societies, and contributing to robust discourse can influence practice and policy. AMA J Ethics. 2020;22(12):E1033-1037. doi: 10.1001/amajethics.2020.1033.
Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542.
Case and Commentary Oct 2023 Should Antipsychotics’ Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults’ Behavioral Symptoms in Short-Staffed Units? Alex Rollo, MD, Jeena Kar, DO, Uma Suryadevara, MD, and Mary Camp, MD This commentary considers how to manage agitation in patients with dementia. AMA J Ethics. 2023;25(10):E725-732. doi: 10.1001/amajethics.2023.725.
Medicine and Society Oct 2023 Prioritizing Diversion and Decarceration of People With Dementia Lay Kodama, MD, PhD, Brie Williams, MD, MS, and Nathaniel P. Morris, MD An aging prison population means more people who are incarcerated will experience dementia and related symptoms. AMA J Ethics. 2023;25(10):E783-790. doi: 10.1001/amajethics.2023.783.